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Abstract The Eurolight project is the ﬁrst at European
Union level to assess the impact of headache disorders, and
also the ﬁrst of its scale performed by collaboration
between professional and lay organizations and individu-
als. Here are reported the methods developed for it. The
project took the form of surveys, by structured question-
naire, conducted in ten countries of Europe which together
represented 60% of the adult population of the European
Union. In Lithuania, the survey was population-based.
Elsewhere, truly population-based studies were impractical
for reasons of cost, and various compromises were
developed. Closest to being population-based were the
surveys in Germany, Luxembourg, the Netherlands, Italy
and Spain. In Austria, France and UK, samples were taken
from health-care settings. In addition in the Netherlands,
Spain and Ireland, samples were drawn from members of
national headache patient organizations and their relatives.
Independent double data-entry was performed prior to
analysis. Returned questionnaires from 9,269 respondents
showed a moderate female bias (58%); of respondents from
patients’ organizations (n = 992), 61% were female. Mean
age of all respondents was 44 years; samples from patients’
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DOI 10.1007/s10194-011-0356-yorganizations were slightly older (mean 47 years). The
different sampling methods worked with differing degrees
of effectiveness, as evidenced by the responder-rates,
which varied from 10.8 to 90.7%. In the more population-
based surveys, responder-rates varied from 11.3 to 58.8%.
We conclude that the methodology, although with differ-
ences born of necessity in the ten countries, was sound
overall, and will provide robust data on the public ill-health
that results from headache in Europe.
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Introduction
Primary headache disorders in Europe, as elsewhere in the
world, are common, disabling and costly [1–3]. They are
also under-recognized and undertreated, so that the burden
of headache in Europe remains unnecessarily high [1].
Amongst the several reasons contributing to this is a lack of
political awareness of the scope and scale of the burden of
headache, which itself is attributable to incomplete
knowledge of these.
The Eurolight project, a collaborative data-collection
exercise in ten countries of Europe initiated by the Center
of Public Health Research (CRP-Sante ´) Luxembourg and
supported by the European Agency for Health and Con-
sumers (EAHC), was designed to address this knowledge
gap. More speciﬁcally its purposes were to estimate, in
Europe, the prevalence and impact of headache disorders of
public-health importance—migraine, tension-type head-
ache (TTH) and chronic headache disorders occurring
on C15 days/month—and use this information to raise
awareness, among the general public, health-care profes-
sionals, health policy-makers and governments of Europe,
of headache as a major cause of public ill-health. Ulti-
mately, its aim was to contribute to the improvement of
health care for headache and the quality of life of people
affected by headache disorders.
This paper describes the structure, organization and
methods of the project.
Project description
The project took the form of surveys by structured ques-
tionnaire, conducted from November 2008 to August 2009,
of population samples from ten countries of Europe rep-
resenting 60% of the adult population of the European
Union: Austria, France, Germany, Ireland, Italy, Lithuania,
Luxembourg, Netherlands, Spain and UK.
The basic methods were developed, tested in a pilot
study in Luxembourg [4] and then reﬁned and ﬁnalized,
with differences in each country (described below).
Partners and committees
The Eurolight project brought together 25 partners from 15
countries: 2 public bodies (CRP Sante ´, Luxembourg, and
Regione Lombardia—Sanita `, Italy); clinicians from 11
hospitals; the professional European Headache Federation
(EHF); 9 European patients’ organizations including the
European Headache Alliance (EHA); the World Headache
Alliance (WHA); and Lifting The Burden (LTB), a non-
governmental organization directing the Global Campaign
against Headache under the auspices of the World Health
Organization (WHO). The project was directed by a Project
Steering Committee (PSC) and overseen by an External
Evaluation Board (EEB).
Theclinicianpartnersandheadacheexpertmembersofthe
PSC were responsible for scientiﬁc quality; the patients’
organization partners ensured relevance of the project to
people affected by headache; LTB contributed methodologi-
calexpertiseacquiredinthepublichealthcontext.Therolesof
the PSC were to develop the protocol according to scientiﬁc
principles, review progress, circumvent practical difﬁculties,
ensure quality control, review the data, plan the analysis and
formulaterecommendationsforfutureactioncontingentupon
the ﬁndings. The EEB was responsible for external quality
evaluation of the project with respect to scientiﬁc relevance
(new knowledge, evidence base and validated content),
patient relevance (all relevant contributors to impact of
headache), ethical aspects (ensuring ethics approvals where
needed) and dissemination. At least one EEB member was
invited to all PSC meetings.
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123Ethics
The National Ethics Committee of Luxembourg gave
overall approval of the protocol. Further approvals were
obtained from national or local ethics committees wherever
needed as the methods for recruitment of participants dif-
fered between countries.
Similarly, data protection approvals were obtained
centrally in Luxembourg and at country levels in compli-
ance with national and European privacy laws.
All potential participants in the project were informed
about the purpose and nature of the study. In most coun-
tries, where questionnaires were mailed, printed informa-
tion leaﬂets in the language of the expected recipient were
enclosed with them. In the Netherlands internet survey, this
information was provided online. In the Lithuania door-to-
door survey, leaﬂets were handed directly to prospective
interviewees and this information was supplemented ver-
bally as required.
Questionnaire development, validation and translation
The Eurolight questionnaire was based on the BURMIG
questionnaire, which itself was developed for the
BURMIG (burden of migraine) study, a Eurolight pilot
study in Luxembourg [4]. Modiﬁcations were made in
the light of the results of that study, and some elements
were imported from other validated sources. Full details
of the development, content and validation of the
Eurolight questionnaire have been described previously
[5].
Initially drafted in English, it was ﬁrst tested among lay
people for intelligibility and face validity, revised as nec-
essary and then translated into Dutch, French, German,
Italian, Lithuanian, Luxembourgish, Portuguese (for part of
the population in Luxembourg) and Spanish in accordance
with the LTB translation protocol for hybrid documents
[6]. The translated versions were tested for comprehensi-
bility, internal consistency and test–retest reliability in 426
headache patients in Austria, France, Germany, Italy, Spain
and UK.
Diagnosis of headache and assessment of impact
Demographic, screening (for headache) and headache-
diagnostic questions (the last based on the international
classiﬁcation of headache disorders, 2nd edition (ICHD-II)
[7]) were supplemented by several question sets addressing
impact, together totalling 103 items.
Only one headache type was diagnosed in each
respondent, those reporting headaches of more than one
type were asked to focus on the one most bothersome to
them. The diagnostic questions were imported, with lin-
guistic adaptation by the PSC as necessary, from the epi-
demiological questionnaire developed by LTB and used in
India (unpublished), China [8] and Russia [9] to differen-
tiate migraine from TTH and identify probable medication-
overuse headache (MOH) amongst other headaches
occurring on C15 days/month. Diagnoses in respondents
with headache on \15 days/month (episodic headache)
were derived, from the responses to these questions, by
means of a computerized algorithm constructed by LTB for
this question set and applying ICHD-II criteria [7]) for, in
order, migraine, TTH, probable migraine and probable
TTH.
Further questions enquired into frequency, intensity and
duration of headache, use of health-care resources (medi-
cation, consultations, investigations and hospitalizations)
and effects of headache on school, work, career, income,
family life, children and household partner. In addition
there were standard questionnaires on lost time (HALT
index [10]), quality of life (WHOQoL-8 [11]) and anxiety
and depression (HADS [12]).
Study populations and sampling methods
The countries participating in the survey (see below) were,
mainly, those of the members of the PSC. They were
selected as a diverse mix of European countries in terms of
population size, health-care system and level of income.
In Lithuania, a country of the former USSR, a region
for which little prior knowledge existed of the prevalence
of headache, a sample was derived from the general
population. In the other countries, all in Western Europe,
true population-based studies were impractical for rea-
sons of cost, and various compromises were developed.
Closest to being population-based were the surveys per-
formed in Germany, Luxembourg, the Netherlands, Italy
and Spain. In Austria, France and UK, samples were
taken from health-care settings. In addition in the Neth-
erlands, Spain and Ireland, samples were drawn from
members of national headache patient organizations and
their relatives.
Full details of sampling methods in each country are set
out below. A summary of the data collection methodology
and the sampled populations is given in Table 1.
Austria
The target population were patients visiting neurologists or
general practitioners (GPs) for any reason. Each of 200
members of the Austrian Neurological Society (O ¨GN) and
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123400 GPs in Upper and Lower Austria and parts of Salz-
burg received ten questionnaires and were asked to dis-
tribute them to consecutive patients aged 18–65 years on
one particular day of a pre-speciﬁed week. Whilst the
sample was potentially 6,000, it was in fact probably
smaller, since it was not known whether all question-
naires were actually handed out. The questionnaires dis-
tinguished between respondents recruited by GPs or
neurologists. Patients were requested to complete and
return them within 1 month; one reminder letter was sent
to those who failed to do so.
France
Here the project was performed with the cooperation of 80
GPs in the Voironnais region, which includes both urban
and rural areas. Each GP received 30 questionnaires and
distributed them to consecutive patients aged 18–65 years
on one particular day of a pre-speciﬁed week. The ques-
tionnaires were completed in the waiting room and handed
back in sealed envelopes. When this was not done, one
reminder letter was sent by e-mail after 1 week.
Germany
A list identifying a randomly selected population-based
sample (n = 3,000) aged 18–65 years was obtained from
the local municipal authority. For an urban/rural mix, half
were drawn from the 580,000 inhabitants of the city of
Essen in North-Rhine Westphalia and half from the 50,000
people living in the town of Kleve and surrounding villages
in the western part of Germany. Questionnaires were dis-
tributed by regular post, with requests to complete and
return them in postage-paid envelopes. No reminders were
sent.
Ireland
Questionnaires were sent by post by the Migraine Asso-
ciation of Ireland (MAI) to their 1,500 patient members;
each was accompanied by a second questionnaire, distin-
guished from the ﬁrst, to be completed by a partner or other
non-biological relative. Reminders were sent electroni-
cally, and information about the survey was included in
MAI’s newsletter and on their website. Recipients were
Table 1 Summarized methodological description of the surveys in ten countries
Survey Target population and mode of distribution of questionnaire
Studies with a general-population basis or conducted in health-care settings
Austria Consecutive patients consulting GPs or neurologists for any reason; questionnaire handed
directly
France Consecutive patients consulting GPs for any reason; questionnaire handed directly
Germany Random general-population sample from urban and rural areas, contacted by regular post
Italy Stratiﬁed general-population sample from urban and rural areas, contacted by regular post
Lithuania General-population sample in and around Kaunas (urban and rural), contacted by door-to-
door cold-calling and personally interviewed by trained medical students
Luxembourg Stratiﬁed general-population sample contacted by regular post
Netherlands-population Stratiﬁed general-population sample contacted by internet
Spain-workplace Stratiﬁed sample of postal services employees, contacted by internal post by occupational
health physicians
UK Consecutive patients attending GPs for any reason; questionnaire handed directly
Studies among members of headache patients’ organization
Ireland Members of MAI and their non-biological relatives, contacted by regular post
Netherlands-patient Random sample of members of NVvHP and (where existing) their non-headache-affected
partners, contacted by regular post
Spain-patient Members of AEPAC and their family; questionnaire distributed by hand via helpers of
AEPAC
Studies among non-responders
Germany-nr Telephone interview
Italy-nr Internet invitation
Luxembourg-nr Telephone interview
Netherlands-nr Telephone interview
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123asked to return the completed questionnaires in postage-
paid envelopes. Each returned questionnaire was checked
to ensure its appropriate origin (member or relative).
Italy
The target population were the 330,000 inhabitants of
Pavia province in the Lombardy region of Northern Italy.
A stratiﬁed sample (n = 3,500), representative with
regard to gender (1:1, F:M ratio), age (within the range
18–65 years), education and habitation (70% urban, 30%
rural) was randomly selected in cooperation with Azienda
Sanitaria Locale (ASL) of Pavia, the local health agency,
who provided the sample list. Questionnaires were dis-
tributed by post, with requests to complete and return them
in postage-paid envelopes. No reminders were sent.
Lithuania
The target populations were the 352,000 inhabitants of
Kaunas city and 89,000 of Kaunas region. A sample
(n = 1,137) representative of the general population for
age (within the range 18–65 years) and habitation (67%
urban, 33% rural) was drawn by computer, using a strati-
ﬁed random sampling method, by the Residents’ Register
Service. Data-collection by cold-calling (visiting house-
holds unannounced) was performed by medical students
trained for the purpose, who personally interviewed con-
senting individuals following the structured questionnaire.
Luxembourg
This country has 235,600 inhabitants aged 18–65 years. A
sample (n = 6,498), representative of the population with
regard to age (in this range), gender, nationality and habita-
tion, was drawn by computer, using a stratiﬁed random sam-
pling method, from the obligatory national social security
registry of the Institut Ge ´ne ´ral de la Se ´curite ´ Sociale. Ques-
tionnaires were sent by post in the language of the recipient
(English, French, German or Portuguese), with requests to
complete and return them in postage-paid envelopes. One
reminder was sent to non-responders 1 month later.
Netherlands
In the Netherlands, there were two surveys of two different
target populations.
One (‘‘Netherlands-population’’) was executed by TNS-
NIPO, a leading market research company with established
access to a large sample of the Dutch population, repre-
sentative with regard to gender, age, habitation, education
and social status according to the standards of the Dutch
National Bureau of Statistics (CBS). Questionnaires were
sent through the internet to those aged 18–65 years within
this sample (n = 200,000). Returned questionnaires with
incomplete answers (other than those relating to income
and body mass index) were automatically rejected. The
study was stopped after 4 days, by which time sufﬁcient
questionnaires had been returned (from 1.2% of those to
whom it was sent).
The second study (‘‘Netherlands-patient’’) targeted the
6,000 members of Nederlandse Vereniging van Hoo-
fdpijnpatie ¨nten (NVvHP), the Dutch headache patients’
organization.Acomputer-selectedrandomsample(n = 500)
was drawn from members aged 18–65 years in a male-to-
femaleratioof1:3,excludingthosewithfacialpainratherthan
headache. Questionnaires were distributed by post, accom-
panied by second distinguishable copies for household part-
ners in cases where they were not themselves affected by
headache; these would be a control group for future analysis.
One reminder letter was sent after 2 weeks (Fig. 1).
Spain
In Spain two surveys were conducted in different
populations.
The ﬁrst (‘‘Spain-workplace’’) was performed among a
sample (n = 1,700) of employees of various companies
operating in the tertiary sector (speciﬁcally the national
postal services) living in ten areas of Spain: Albacete,
Barcelona, Cadiz, Castello ´n, Cuenca, Ibiza, Palma de
Mallorca, Teruel, Valencia and Zaragoza. The sample was
stratiﬁed with regard to gender (male-to-female ratio of
1:1), age (within the range 18–65 years) and education.
Ten occupational health physicians delivered and took
return of the questionnaires. One reminder by telephone
was issued to non-responders.
The second study (‘‘Spain-patient’’) was performed by
the Asociacio ´n Espan ˜ola Pacientes con Cefalea (AEPAC),
the Spanish headache patients’ organization. Helpers of
AEPAC distributed 300 questionnaires personally among
its members, and their families, living in and around
Valencia. One reminder, by telephone or face-to-face, was
given to non-responders.
UK
The targeted population in the UK were patients of 12
general practices in 11 towns or cities: Aberdeen, Brighton,
Cambridge, Cuddlington, Eastbourne, Exeter, Grantham,
J Headache Pain (2011) 12:541–549 545
123Guildford, Norwich, Tenterden and Weymouth. Each
practice received 60 questionnaires to hand to consecutive
patients attending for any reason. Recipients were asked to
complete them in the waiting room and return them
immediately, but they could also complete them later and
return them by post. There were no reminders.
Non-responder studies
It was likely, especially where responder-rates were low, that
questionnaires would be returned preferentially by people
most affected by headache, a potential source of signiﬁcant
bias. To estimate the probability and magnitude of this bias,
10%ofallnon-respondersinLuxembourg,GermanyandItaly
(stratiﬁed for age, gender and, in Luxembourg only, nation-
ality) and 10% of those in the Netherlands population-based
studywhorepliedwithintheﬁrst4 daysthattheydidnotwish
to complete the original questionnaire were re-contacted
either by telephone or (in the case of Italy) by internet
(Table 1, lower part). They were asked a few questions only:
whether headache had occurred during the last year, three
questions fromID migraine(a migraine screening instrument
[13] allowing the identiﬁcation of likely migraineurs) and
questions on headache frequency and on headache, if any, on
the previous day.
Data entry
Independent double data-entry was performed in all cases:
by two students in Austria, by two secretaries in France, by
two students supervised by a physician in Germany, by a
professional information ofﬁcer and administrative staff in
Ireland, in part by two members of the research team and in
part by data-management personnel of CRP-Sante ´ for Italy,
by two members of the research team in Lithuania, by two
students supervised by the scientiﬁc data-management
leader of CRP-Sante ´ in Luxembourg, by personnel from
Het Ondersteuningsburo (HOB), an administrative support
organization employed by NVvHP, in the Netherlands, by
administrative staff of AEPAC in Spain and in part by two
administrative staff members of Migraine Action UK and
in part by data-management personnel of CRP-Sante ´ for
the UK.
Data management and quality control
These were the responsibility of CRP-Sante ´,w h oi s s u e d
detailed instructions on data entry and developed a database
and means of electronic transfer via a secure web application
to the central collecting point. All hard-copy completed
questionnaireswerealsosenttoCRP-Sante ´.Theseprocedures
wereapprovedbythe National DataProtectionCommitteein
Luxembourg and tested for reliability and practicability dur-
ing validation of the questionnaire [5].
The two sets of entered data from each country were
compared at CRP-Sante ´ and the discrepancies resolved by
reference to the original questionnaires. The database was
then locked prior to analysis.
Results
The detailed results will be presented in future publications
(along with analytical methods). Here we recount the
results that reﬂect upon the methodology. Altogether, 9,269
correctly completed returned questionnaires were analyzed.
They had a moderate female bias (58%: Table 2); of the
respondents from the three patients’ organizations
(n = 992), 61% were female. The mean age of all
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123respondents was 44 years; samples from patients’ organi-
zations were slightly older (mean 47 years) (Table 2).
The different sampling methods adopted in these ten
countries worked with differing degrees of effectiveness, as
evidenced by the responder-rates, which varied from 11.3
to 90.7% (Table 2). In the more population-based surveys,
responder-rates varied from 11.3 to 54.2% (achieved in the
door-to-door survey in Lithuania) and 58.8% (in the work-
force population in Spain).
The samples were mostly of employed people of normal
working age, and most were married or living with
household partners.
Altogether, 1,007 people (51% female) participated in
the non-responder studies. The responder-rates in these
studies were generally high (Germany 80%; Luxembourg
87%; Netherlands 72%), although in Italy the denominator
and, therefore, the responder-rate were unknowable.
Discussion
An important feature of this study was that the same
questionnaire was used in ten countries, constructed spe-
ciﬁcally for the project, revised after pilot studies, validated
[4, 5] and translated into all local languages according to a
rigorous translation protocol [8]. Although the diagnostic
ability of the questionnaire was not assessed for accuracy
within the project, the diagnostic question set had been
used by LTB, in the local languages, for epidemiological
studies in India (unpublished), China [8] and Russia [9]. In
these countries, sensitivity and speciﬁcity were 63–77%
and 82–99%, respectively, for migraine and 51–64% and
81–99% for TTH. Low sensitivity for TTH relative to
diagnosis by headache experts reﬂects the fact that TTH is
commonly infrequent (occurring less than once per month)
and, therefore, not reported. Missing these cases makes
little difference to estimates of impact.
To this extent the methods were constant. However,
different sampling methods developed for the various
surveys in these ten countries were the result of necessary
compromises.
Truly population-based studies, ideally conducted door-
to-door as in Lithuania, are highly resource-consuming and
may be unjustiﬁable (even if practical) in a study of this
scope and scale. There has to be regard for cost/beneﬁt
when considering levels of resource-investment, and this is
what drove the compromises. In fact, the different meth-
odologies were both a strength and a potential weakness of
the study. They were a strength because different methods
have different drawbacks, so the use of a variety of
methods can yield more robust results overall. It would be
a deﬁnite weakness if the purpose had been to compare the
different countries, but this was not the case: Eurolight’s
endeavour was aimed at estimating the impact of headache
in Europe and, from that point of view, the mix of methods
was not undesirable.
Table 2 Responder-rates, gender distribution and mean age of samples in each survey
Survey Denominator (n) Responders
(n)
Responder-rate
(%)
Gender
(% female)
Age (year)
mean (SD)
Austria Unknown, but not[6,000 646 Incalculable 70 48.8 (16.0)
France 2,400 876 36.5 68 50.2 (16.7)
Germany 3,000 338 11.3 57 44.6 (12.5)
Ireland Members 1,500 195 13.0 66 49.4 (14.0)
Relatives unknown 73 Incalculable
Italy 3,500 500 14.3 58 43.4 (12.6)
Lithuania 1,137 616 54.2 59 40.9 (13.8)
Luxembourg 6,498 2,023 31.1 58 40.5 (12.7)
Netherlands-population Unknown 2,414 Incalculable 50 42.6 (13.2)
Netherlands-patient Members 500 337 67.4 57 48.6 (10.6)
Partners unknown 115 Incalculable
Spain-workplace 1,700 999 58.8 59 42.7 (11.9)
Spain-patient 300 272 90.7 62 41.6 (11.4)
UK 720 128 17.8* 65 48.0 (18.3)
Non-responder studies
Germany-nr 260 55 Unknown
Italy-nr 202 70 39.4
Luxembourg-nr 357 50 Unknown
Netherlands-nr 188 52 38.9
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123Less satisfactory were the variable and generally rather
low responder-rates (Table 2), despite that the total sample
size was large (n = 9,532). Low responder-rates may
introduce bias. The key issue is whether samples were
representative not only of the populations from which they
were immediately derived but, more broadly and more
importantly, from the general populations of the countries
and of Europe (at least within the adult age range, usually
18–65 years, to which we restricted the surveys).
The highest responder-rates in non-patient groups were
in Lithuania (54.2%), a door-to-door survey conducted by
trained interviewers which, probably, provided more
incentive to answer than the self-administration demanded
elsewhere, and in the relatively captive work-force popu-
lation of Spain-workplace (58.8%). We regard only the
Lithuania study as truly population-based: all others were
approximations, at varying distances, either because the
sampling base was restricted as in Spain-workplace (a
working population cannot be regarded as entirely repre-
sentative of the full population even when the latter is
limited to the working age-range) or because low respon-
der-rates raised uncertainties about representativeness
despite a broad sampling base (e.g., the 11.3% in
Germany). In Italy and Luxembourg, samples were stratiﬁed
for gender, age and habitation to achieve representative-
ness, but low responder-rates (14.3 and 31.1%) undermined
this. In Netherlands-population, the sample contacted
through the internet was representative but the study was
stopped when only 1.2% had answered; the denominator
(the number who had an opportunity to respond within
the 4 days) was unknowable and, therefore, so are
the responder-rates and degree of representativeness. In
Austria, France and UK, samples were taken from patient
populations, but not exclusively from headache patients. In
UK, virtually all inhabitants are registered with their local
GPs, so GPs’ lists are generally representative of the local
population. Nevertheless, people with cause to visit doctors
are, presumably, less healthy than the general population.
They are also likely to be older, and this was borne out,
and women were more highly represented (Table 2).
Clearly the samples from members of patient organizations
were not expected to be representative. What becomes of
interest in these circumstances is how ﬁndings differed
between the samples, even though this was not a purpose of
the project.
Age and gender are important factors inﬂuencing the
prevalence of headache, but imbalances in these are readily
recognized and easily adjusted for during analyses. More
problematic, because it is not only likely but also much
more difﬁcult to detect, is ‘‘interest-bias’’. People with
headache are more inclined to respond to a questionnaire
about headache, and this inclination is, almost certainly,
positively correlated with level of burden attributable to
headache. This was the reason for conducting the non-
responder studies: to detect at least whether the prevalence
of headache was markedly lower amongst non-responders
and, if so, to provide data whereby we could estimate
uncertainties in the main ﬁndings.
The project was one of few so far to assess the separate
impacts of migraine, TTH and MOH. It will, therefore, be
possible to make comparisons between these. This may be
of considerable interest, particularly with regard to time
and productivity losses, effects on quality of life and
ﬁnancial costs. The samples were mostly of employed
people, married or living with household partners. Good
opportunities were created, therefore, to assess impact of
headache beyond its effects on people with it: on work and
productivity, and on family.
Conclusion
The Eurolight project was the ﬁrst at European Union level
to assess the impact of headache disorders, and also the ﬁrst
project of its scale performed by a collaboration between
professional and lay organizations and individuals. The
methodology, although with differences born of necessity
in the various surveys in the ten countries, was sound
overall; biases should be detectable and their effects miti-
gated. In conclusion, we believe Eurolight will provide
robust data revealing the amount of public ill-health that
results from headache in Europe and carrying a very
important message to health policy-makers.
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Zu ¨rich Switzerland), Jean Schoenen (Headache Research
Unit, University Department of Neurology, Citadelle
Hospital, Lie `ge, Belgium).
Associated Partners: Ge ´rard Mick (Re ´seau Voironnais
de la Douleur), Daiva Rastenyte (Lithuanian University of
Health Sciences, Kaunas, Lithuania), Anne MacGregor
(The City of London Migraine Clinic, London, UK),
Asociacion Espan ˜ola de Pacientes con Cefalea (Spain),
Migraine Action (UK), Migraine Association of Ireland
(Ireland), Nederlandse Vereniging van Hoofdpijnpatienten
(The Netherlands), European Headache Alliance, European
Headache Federation, Lifting The Burden: the Global
Campaign against Headache.
Collaborating Partners: Judit Afra (National Institute of
Neurosurgery, Budapest, Hungary), Marta Allena (National
Neurological Research Institute C Mondino Foundation,
Pavia, Italy), Bruno Carugno, (Azienda Sanitaria Locale of
Pavia, Italy), Jean-Marie Ge ´rard (Ligue Belge Contre les
Cephale ´es, Nimy, Belgium), Heidy Hauser (Migraine
Action Switzerland, Bottmingen, Switzerland), Carlo
Lucchina (Regione Lombardia—Sanita `, Italy), Giuseppe
Nappi (National Neurological Research Institute C Mon-
dino Foundation, Pavia, Italy), Konventhospital Barm-
herzige Bru ¨der (Linz, Austria), Neurology Group of the
Spanish Society of Occupational Practitioners (AEMMT),
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